Vaccination rates and the onset of cervical adenocarcinoma are both rising, making HPV genotype testing an essential tool for risk stratification and patient management. High-risk HPV genotypes 16, 18 are responsible for 70% of cervical cancer worldwide.
Tianlong’s Human Papillomavirus (HPV) Nucleic Acid Detection Kit is a qualitative in vitro test for the identification of 18 high-risk HPV types (HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82), which can specifically identify HPV 16 and HPV 18 while simultaneously detecting the remaining high-risk types.

Image Credit: Xi'an Tianlong Science and Technology Co., Ltd

Image Credit: Xi'an Tianlong Science and Technology Co., Ltd
Features
- High Precision: The coefficient of variation of the Ct values (CV%) is less than 5%
- More accurate: Collocating with Tianlong's extraction reagent improves the accuracy of the experiment results
- Internal Control: The kit’s use of an internal control system can effectively prevent false negative results
- User-friendly: Applicable in instruments with FAM, HEX/VIC, CY5, and TEXAS RED/ROX channels
- Concurrently detects remaining 16 HPV genotypes: 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82 Positive or Negative Pooled Result

Image Credit: Xi'an Tianlong Science and Technology Co., Ltd
Specifications
Source: Xi'an Tianlong Science and Technology Co., Ltd
Product Name |
Human Papillomavirus (HPV) Nucleic Acid Detection Kit (Fluorescence PCR method) |
Cat.No |
P120H |
Specification |
32T/kit |
Sensitivity |
500copies/ml |
Specimen |
Female cervical epithelial cells |
Type of Analysis |
qualitative |
Storage and Validity |
-25 ℃~-15 ℃ for 12 months |
Applicable Equipment |
Instruments with FAM 、HEX/VIC、Y5 and TEXAS RED/ROX channels, such as ABI7500 real time PCR systems, TL988-IV, Gentier series real time PCR systems |